Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2006
06/28/2006CN1261439C Cefixime sodium pharmaceutical composition and its preparation and application
06/28/2006CN1261437C Glycine-substituted thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
06/28/2006CN1261436C Bibenzil compound 13,13'-O-iso-propylidene riccardia D and its extraction and separation method and use
06/28/2006CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists
06/28/2006CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
06/28/2006CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
06/28/2006CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles
06/28/2006CN1261419C Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
06/28/2006CN1261416C Perfuoroalkylamide, prodn. and use in diagnostics thereof
06/28/2006CN1261414C Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B)
06/28/2006CN1261412C Indole derivatives as COXII inhibitors
06/28/2006CN1261165C Preparation for prophylaxis of restenosis
06/28/2006CN1261164C Medicine for burn and scald and its preparation
06/28/2006CN1261163C Stabilization of macrolides
06/28/2006CN1261150C Chinese medicine for health preserving and fat reducing by umbilical treatment
06/28/2006CN1261142C Use of a serra repens extract for the production of a medicament to treat prostate cancer
06/28/2006CN1261140C Medicine for treating burns and scalds
06/28/2006CN1261129C External used Chinese medicine plaster for removing obstruction in channel powder
06/28/2006CN1261128C Medicine for treating burn and scald, preparing method thereof
06/28/2006CN1261117C Medicine for treating bum, empyrosis and bedsore
06/28/2006CN1261110C Medicinal composition for treating common and infectious cold
06/28/2006CN1261107C Chinese medicine for treating eczema and dermatitis
06/28/2006CN1261106C Externally applied liquor for treating psoriasis and preparation method
06/28/2006CN1261105C Encephalic proteolytic products of compound Piracetam and its preparation method
06/28/2006CN1261104C Glossy-ganoderma-spore polysaccharide for injection and its preparation process
06/28/2006CN1261103C Anticancer microbial drug material, its preparing method and usage
06/28/2006CN1261102C Complement inhibitor
06/28/2006CN1261101C Chitosan glycyrrhizie acid nano particle and its preparing method
06/28/2006CN1261100C Medicinal composition containing triphenyl-boroxin for boron neutron catching treatment
06/28/2006CN1261099C Tetrahydroquinoline derivatives
06/28/2006CN1261098C p38-alpha kinase inhibitors
06/28/2006CN1261097C Nisoldipine capsule composition
06/28/2006CN1261096C Compound preparation of reveratrol and application
06/28/2006CN1261095C Brain, spinal and nerve injure treatment
06/28/2006CN1261094C New use of lipase inhibitors
06/28/2006CN1261093C Use of glutaraldehyde in preparing medicine for preventing animal toxic diseases
06/28/2006CN1261092C New use of glutaraldehyde in preparing animal medicine
06/27/2006USRE39151 Process for the preparation and purification of thiol-containing maytansinoids
06/27/2006USRE39150 Composition for creating vascular occlusions
06/27/2006USRE39149 Method of administering azithromycin
06/27/2006US7067694 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
06/27/2006US7067682 6,7-Oxygenated steroids and uses related thereto
06/27/2006US7067681 Nitration of tetracyclines and derivatives, then reducing, diazotizing and alkylation on the presence of palladium chloride; catalysis; antibiotics
06/27/2006US7067679 Therapy for breast cancer; plant extracts
06/27/2006US7067678 deprotonation of nepetalactone and treatment with Grignard reagent to form 3-alkyl and -aryl substituted compounds that are useful as insect repellents, especially biting flies, chiggers, fleas, mosquitoes, ticks and lice.
06/27/2006US7067672 metallating a nicotine derivative with a metal base complex to form an organometallic intermediate, which is reacted with a halogenating agent, especially I2, C2Cl6, N-bromosuccinimide, Br2, N-iodosuccinimide, CCl4, or 1,3-dichloro-5,5-dimethylhydantoin.
06/27/2006US7067670 Sulfamato hydroxamic acid metalloprotease inhibitor
06/27/2006US7067669 combining 6-hydroxy-3,4-dihydroquinolinone and an alkali metal carbonate; removing water using molecular sieves; adding 1-cyclohexyl-5-(4-halobutyl)-tetrazole; and recovering cilostazol.
06/27/2006US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors
06/27/2006US7067666 7-substituted camptothecin and camptothecin analogs and methods for producing the same
06/27/2006US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses
06/27/2006US7067664 Corticotropin releasing factor antagonists
06/27/2006US7067659 allopurinol, oxypurinol, or pterin-6-aldehyde derivatives containing one or more nitrate groups, used for heart failure and stable angina
06/27/2006US7067658 Anxiolytic agents; antidepressants; Alzheimer, Huntington, Parkinson disease
06/27/2006US7067657 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain
06/27/2006US7067655 Adenosine A2a receptor antagonists
06/27/2006US7067651 Non-synthetic biodegradable starch-based composition for production of shaped bodies
06/27/2006US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis.
06/27/2006US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines
06/27/2006US7067629 Sodium channel in dorsal root ganglia
06/27/2006US7067557 Stimulating the body's production of testosterone to correct male menopause, loss of cognitive function, insulin resistance, type 2 diabetes, obesity, excessive weight, and Alzheimer's disease
06/27/2006US7067556 Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
06/27/2006US7067555 Sertraline oral concentrate
06/27/2006US7067554 Method for the synthesis of compounds of formula I and their uses thereof
06/27/2006US7067553 Thiourea compounds and the pharmaceutical compositions containing the same
06/27/2006US7067552 Radiosensitizing taxanes and their pharmaceutical preparations
06/27/2006US7067551 Deacetylase inhibitors
06/27/2006US7067550 Treatments for neurotoxicity in Alzheimer's Disease
06/27/2006US7067549 Pyrrolidone carboxamides
06/27/2006US7067548 Non-emetic 1-phenyl- or pyridyl-pyrazoles.
06/27/2006US7067547 a preservative and water; improved resistance to protein depositions; decreased denaturalization of proteins during cleaning cycles
06/27/2006US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius
06/27/2006US7067545 Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
06/27/2006US7067544 a high purity epothilone from Sorangium cellulosum; anticarcinogenic, antitumor agents
06/27/2006US7067543 Anthranilic acid amides and pharmaceutical use thereof
06/27/2006US7067542 Diaminediols for the treatment of Alzheimer's disease
06/27/2006US7067541 2-amino-pyridine derivatives useful for the treatment of diseases
06/27/2006US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders
06/27/2006US7067539 Cannabinoid receptor ligands
06/27/2006US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection
06/27/2006US7067537 Anticancer, antitumor agents
06/27/2006US7067536 phosphodiesterase 4 inhibitors in immunocompetent cells, such as macrophages and lymphocytes; side effect reduction; N-(3,5-dichloro-1-oxopyridin-4-yl)-[7-hydroxy-1-(3- or 2-nitrobenzyl)-indol-3-yl]glyoxylamide
06/27/2006US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis
06/27/2006US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence
06/27/2006US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
06/27/2006US7067532 Substituted quinolines as antitumor agents
06/27/2006US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent
06/27/2006US7067530 Compounds may be useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR). The compounds exert their effects by modulating the PPAR gamma
06/27/2006US7067529 a 1-benzoyl-6- or 7-methoxy-isoquinoline; antidiabetic agents; Type II diabetes
06/27/2006US7067528 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative
06/27/2006US7067527 Thienopyridine derivatives, their production and use
06/27/2006US7067526 28-epirapalogs
06/27/2006US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same
06/27/2006US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol
06/27/2006US7067523 Use of pyrone carboxylates for controlling pests
06/27/2006US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors
06/27/2006US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives
06/27/2006US7067520 Antidiabetic agents; hypoglycemic agents; antilipemic agents; dietetics
06/27/2006US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia
06/27/2006US7067518 Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents